Prohibitin (PHB) is a worthwhile target for future investigations according to its overexpression in the prostate cancer cells (PC3) at T120 zinc exposure compared to the normal counterparts (Table 2) as well as its prominence in the functional protein network of PC3 T120 vs RWPE-1 T120 (Supplementary Figure 10b). Here, PHB1 is linked to prostate cancer.